TZDs (Pioglitazone) for Type 2 Diabetes: Pharmacology Review episode artwork

EPISODE · Jan 27, 2026 · 16 MIN

TZDs (Pioglitazone) for Type 2 Diabetes: Pharmacology Review

from This Is Why with Dr. Busti · host Anthony Busti, MD, PharmD, MSc, FNLA, FAHA

In this lecture from This is Why, Dr. Busti will break down pioglitazone and the thiazolidinediones (TZDs) so you can confidently explain the mechanism, clinical use, side effects, and key contraindications for type 2 diabetes (T2DM).You’ll learn how to:- TZDs (pioglitazone): where they fit in type 2 diabetes (T2DM) therapy- Mechanism of action: PPAR-γ agonist → increased insulin sensitivity (muscle/adipose) and improved glucose utilization- Expected impact on A1C reduction and how long these drugs take to show benefit- Practical comparisons: pioglitazone vs rosiglitazoneSide effects & safety (high yield)- Weight gain and edema / fluid retention- Heart failure risk (when to avoid TZDs)- Fracture risk with TZDsDrugs covered for SEO / review- Pioglitazone (primary focus)- Thiazolidinediones / TZDs (drug class)- Rosiglitazone (comparison)The goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/tzd-thiazolidinediones-pioglitazone-type-2-diabetes-pharmacology-reviewGet more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#pioglitazone #thiazolidinediones #tzd #type2diabetes #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Episode metadata supplied by the publisher feed · Published Jan 27, 2026

Embed this episode

In this lecture from This is Why, Dr. Busti will break down pioglitazone and the thiazolidinediones (TZDs) so you can confidently explain the mechanism, clinical use, side effects, and key contraindications for type 2 diabetes (T2DM). You’ll learn how to: - TZDs (pioglitazone): where they fit in type 2 diabetes (T2DM) therapy - Mechanism of action: PPAR-γ agonist → increased insulin sensitivity (muscle/adipose) and improved glucose utilization - Expected impact on A1C reduction and how long...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

TZDs (Pioglitazone) for Type 2 Diabetes: Pharmacology Review

0:00 16:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of This Is Why with Dr. Busti?

This episode is 16 minutes long.

When was this This Is Why with Dr. Busti episode published?

This episode was published on January 27, 2026.

Can I download this This Is Why with Dr. Busti episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!